Posted by on March 23, 2018 2:45 pm
Categories: Crispr Articles

Source: CRISPR Startup Arbor Biotechnologies, Salk Institute Concurrently Discover New Cas13d Enzyme

NEW YORK (GenomeWeb) – With $15.6 million in Series A funding, early-stage life sciences company Arbor Biotechnologies came out of stealth mode last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.

Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Published at Fri, 23 Mar 2018 14:41:50 +0000

Leave a Reply